CEACAM5 and breast cancer: These include the presence of specific antigens, changes in enzyme activities, and unique changes in DNA and proteins, for example, carcinoembryonic antigen (CEA) in colorectal cancer [10], chitinase enzyme activity in Alzheimer’s disease [11], and circulating tumor DNA in breast cancer [12].